Your leading voice in digital health news
Twitter X Logo

Identifai Genetics lists on ASX after $10m IPO

14 October 2026
By Reesh Lyon
Prenatal genetic screening company Identifai Genetics has listed on the Australian Securities Exchange (ASX) following a $10 million initial public offering, with funds to support clinical validation and commercialisation of its AI-enabled screening technology in the United States. The company began trading this week under the ticker ID1 after raising $10 million at $0.20 per […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down